Vaccinex, Inc. (VCNX) Financials

VCNX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2025 2.6 million 5.1 million
Dec. 31, 2024 2.6 million 5.1 million
Sept. 30, 2024 4.9 million 6.2 million
June 30, 2024 2.4 million 5.2 million

VCNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2025 -3.9 million 57000
Dec. 31, 2024 -3.9 million 57000
Sept. 30, 2024 -3.2 million 76000
June 30, 2024 -4.4 million 112000

VCNX Net Income

No data available :(

VCNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2025 1.1 million - -
Dec. 31, 2024 1.1 million - -
Sept. 30, 2024 2.9 million - 15000
June 30, 2024 233000 - 59000

VCNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2025 2.1 million
Dec. 31, 2024 2.7 million
Sept. 30, 2024 2.0 million
June 30, 2024 1.8 million

VCNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2025 - 2.1 million 1.5 million -
Dec. 31, 2024 - 2.1 million 1.5 million -
Sept. 30, 2024 8000 3.2 million 1.4 million -
June 30, 2024 14000 3.9 million 2.1 million 1

VCNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2025 213000 -
Dec. 31, 2024 213000 -
Sept. 30, 2024 52000 24000
June 30, 2024 232000 25000

VCNX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VCNX

Price: $1.01

52 week price:
0.31
1.50

Earnings Per Share: -8.88 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 494085

Market Capitalization: 2.7 million

Links: